These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 38040675)
1. Emerging role and therapeutic implications of p53 in intervertebral disc degeneration. Wang Y; Hu S; Zhang W; Zhang B; Yang Z Cell Death Discov; 2023 Dec; 9(1):433. PubMed ID: 38040675 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment. Wang Y; Cheng H; Wang T; Zhang K; Zhang Y; Kang X Cell Prolif; 2023 Sep; 56(9):e13448. PubMed ID: 36915968 [TBL] [Abstract][Full Text] [Related]
3. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain? Li W; Lai K; Chopra N; Zheng Z; Das A; Diwan AD Eur Spine J; 2022 Apr; 31(4):917-925. PubMed ID: 35286474 [TBL] [Abstract][Full Text] [Related]
4. Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc. Feng C; Liu H; Yang Y; Huang B; Zhou Y Cell Physiol Biochem; 2015; 35(1):1-16. PubMed ID: 25547527 [TBL] [Abstract][Full Text] [Related]
5. Unraveling the mechanisms of intervertebral disc degeneration: an exploration of the p38 MAPK signaling pathway. Zhang X; Zhang Z; Zou X; Wang Y; Qi J; Han S; Xin J; Zheng Z; Wei L; Zhang T; Zhang S Front Cell Dev Biol; 2023; 11():1324561. PubMed ID: 38313000 [TBL] [Abstract][Full Text] [Related]
8. Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions. Kamali A; Ziadlou R; Lang G; Pfannkuche J; Cui S; Li Z; Richards RG; Alini M; Grad S Theranostics; 2021; 11(1):27-47. PubMed ID: 33391459 [TBL] [Abstract][Full Text] [Related]
9. Natural products can modulate inflammation in intervertebral disc degeneration. Liu Z; Zhu J; Liu H; Fu C Front Pharmacol; 2023; 14():1150835. PubMed ID: 36874009 [TBL] [Abstract][Full Text] [Related]
10. The role of IL-1β and TNF-α in intervertebral disc degeneration. Wang Y; Che M; Xin J; Zheng Z; Li J; Zhang S Biomed Pharmacother; 2020 Nov; 131():110660. PubMed ID: 32853910 [TBL] [Abstract][Full Text] [Related]
11. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals. Kang L; Zhang H; Jia C; Zhang R; Shen C Front Pharmacol; 2022; 13():956355. PubMed ID: 35903342 [TBL] [Abstract][Full Text] [Related]
12. MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration. Zhang HJ; Liao HY; Bai DY; Wang ZQ; Xie XW Biomed Pharmacother; 2021 Nov; 143():112170. PubMed ID: 34536759 [TBL] [Abstract][Full Text] [Related]
13. Vascular anatomy-based localization of intervertebral discs assisting needle puncture for constructing a mouse model of mechanical injury-induced lumbar intervertebral disc degeneration. Zhang L; Du G; Teng B; Shi X; He X; Li N; Chen Y; Xu R Biochem Biophys Res Commun; 2022 Dec; 634():196-202. PubMed ID: 36265418 [TBL] [Abstract][Full Text] [Related]
14. From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation. Yang S; Jing S; Wang S; Jia F Front Cell Infect Microbiol; 2024; 14():1303645. PubMed ID: 38352058 [TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy. Zhang XB; Hu YC; Cheng P; Zhou HY; Chen XY; Wu D; Zhang RH; Yu DC; Gao XD; Shi JT; Zhang K; Li SL; Song PJ; Wang KP Int J Med Sci; 2021; 18(13):2799-2813. PubMed ID: 34220308 [TBL] [Abstract][Full Text] [Related]
16. Intervertebral disc degeneration and inflammatory microenvironment: expression, pathology, and therapeutic strategies. Chen X; Wang Z; Deng R; Yan H; Liu X; Kang R Inflamm Res; 2023 Sep; 72(9):1811-1828. PubMed ID: 37665342 [TBL] [Abstract][Full Text] [Related]
17. ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration. Feng C; Yang M; Lan M; Liu C; Zhang Y; Huang B; Liu H; Zhou Y Oxid Med Cell Longev; 2017; 2017():5601593. PubMed ID: 28392887 [TBL] [Abstract][Full Text] [Related]
18. Disc cell senescence in intervertebral disc degeneration: Causes and molecular pathways. Feng C; Liu H; Yang M; Zhang Y; Huang B; Zhou Y Cell Cycle; 2016 Jul; 15(13):1674-84. PubMed ID: 27192096 [TBL] [Abstract][Full Text] [Related]
19. The mechanisms and functions of TNF-α in intervertebral disc degeneration. Pan H; Li H; Guo S; Wang C; Long L; Wang X; Shi H; Zhang K; Chen H; Li S Exp Gerontol; 2023 Apr; 174():112119. PubMed ID: 36758650 [TBL] [Abstract][Full Text] [Related]
20. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Jin LZ; Lu JS; Gao JW Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29700214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]